M. Duquette

发表

Thrombospondins in early Xenopus embryos: Dynamic patterns of expression suggest diverse roles in nervous system, notochord, and muscle development

J. Lawler, D. DeSimone, C. A. Whittaker, 1998, Developmental dynamics : an official publication of the American Association of Anatomists.

Thrombospondin-1 Modulates Actin Filament Remodeling and Cell Motility in Mouse Mammary Tumor cells in Vitro

J. Lawler, S. Kazerounian, M. Duquette, 2014, Discoveries.

Thrombospondin‐1 modulates vascular endothelial growth factor activity at the receptor level

H. Dvorak, J. Nagy, J. Lawler, 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

The effect of thrombospondin-1 on breast cancer metastasis

J. Lawler, S. Kazerounian, M. Duquette, 2009, Breast Cancer Research and Treatment.

Purification and Analysis of Thrombospondin‐1

A. Ludlow, J. Lawler, M. Duquette, 2003, Current protocols in cell biology.

Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells with BRAFV600E: New Insights in the Host Tissue Adaptation and Homeostasis of Tumor Microenvironment

C. Nucera, J. Lawler, P. Sadow, 2013, Front. Endocrinol..

Fatty acid synthesis is required for breast cancer brain metastasis

T. Golub, J. Nielsen, D. Housman, 2021, Nature Cancer.

Thrombospondin-1 Interacts with Trypanosoma cruzi Surface Calreticulin to Enhance Cellular Infection

S. Pratap, P. Nde, M. Lima, 2012, PloS one.

Thrombospondin-1 type 1 repeat recombinant proteins inhibit tumor growth through transforming growth factor-beta-dependent and -independent mechanisms.

J. Lawler, P. Lawler, W. Miao, 2001, Cancer research.

Expression and mutagenesis of thrombospondin.

J. Lawler, M. Duquette, P. Ferro, 1992, Biochemistry.

Cloning and sequencing of chicken thrombospondin.

J. Lawler, M. Duquette, P. Ferro, 1991, The Journal of biological chemistry.

Continuous administration of the three thrombospondin-1 type 1 repeats recombinant protein improves the potency of therapy in an orthotopic human pancreatic cancer model.

J. Lawler, S. Parangi, Xuefeng Zhang, 2007, Cancer letters.

Priming of the vascular endothelial growth factor signaling pathway by thrombospondin-1, CD36, and spleen tyrosine kinase.

R. Khosravi‐Far, J. Lawler, Keli Song, 2011, Blood.

Members of the thrombospondin gene family bind stromal interaction molecule 1 and regulate calcium channel activity

M. Nadler, J. Lawler, T. Shuttleworth, 2014, Matrix biology : journal of the International Society for Matrix Biology.

Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice

R. Jain, D. Fukumura, Somin Lee, 2022, Journal for ImmunoTherapy of Cancer.

A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR.

R. Khosravi‐Far, J. Lawler, B. Ren, 2009, Cancer research.

The structures of the thrombospondin-1 N-terminal domain and its complex with a synthetic pentameric heparin.

Jia-huai Wang, Mark Duquette, Rongguang Zhang, 2006, Structure.

Identification and characterization of thrombospondin-4, a new member of the thrombospondin gene family

J. Lawler, J. Adams, D. DeSimone, 1993, Journal of Cell Biology.

Characterization of the murine thrombospondin gene.

N. Copeland, D. Gilbert, N. Jenkins, 1991, Genomics.

Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model

P. Pandolfi, T. Giordano, A. Fischer, 2015, Oncotarget.

Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia.

R. Hynes, J. Lawler, E. L. George, 1998, The Journal of clinical investigation.

Role of BRAFV600E in the first preclinical model of multifocal infiltrating myopericytoma development and microenvironment.

J. Clohessy, P. Pandolfi, E. Palescandolo, 2014, Journal of the National Cancer Institute.

Combined therapy with thrombospondin‐1 type I repeats (3TSR) and chemotherapy induces regression and significandy improves survival in a preclinical model of advanced stage epithelial ovarian cancer

R. Drapkin, J. Lawler, J. Petrik, 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Antiangiogenic Treatment with Three Thrombospondin-1 Type 1 Repeats versus Gemcitabine in an Orthotopic Human Pancreatic Cancer Model

J. Lawler, S. Parangi, Xuefeng Zhang, 2005, Clinical Cancer Research.

Antiangiogenic Treatment with the Three Thrombospondin-1 Type 1 Repeats Recombinant Protein in an Orthotopic Human Pancreatic Cancer Model

J. Lawler, S. Parangi, Xuefeng Zhang, 2005, Clinical Cancer Research.

Thrombospondin-1 gene expression affects survival and tumor spectrum of p53-deficient mice.

R. Hynes, R. Bronson, N. Bouck, 2001, The American journal of pathology.

Crystal structure of the TSP-1 type 1 repeats

A. Joachimiak, Rongguang Zhang, K. Tan, 2002, The Journal of cell biology.

Baseline characteristics of patients with atrial fibrillation: The AFFIRM Study

P. H. Beadle, A. Skadsen, S. Swiryn, 2002 .

The evolution of the thrombospondin gene family

Mark Duquette, Temple F. Smith, J. Lawler, 1993, Journal of Molecular Evolution.

Characterization of Human Thrombospondin-4 (*)

J. Lawler, Laura Derick, M. Duquette, 1995, The Journal of Biological Chemistry.

The crystal structure of the signature domain of cartilage oligomeric matrix protein: implications for collagen, glycosaminoglycan and integrin binding

A. Joachimiak, K. Tan, J. Lawler, 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models

R. Jain, G. Freeman, A. Sharpe, 2022, bioRxiv.

Heparin-induced cis- and trans-Dimerization Modes of the Thrombospondin-1 N-terminal Domain*

A. Joachimiak, K. Tan, J. Lawler, 2008, Journal of Biological Chemistry.

The crystal structure of the heparin-binding reelin-N domain of f-spondin.

K. Tan, J. Lawler, Jia-huai Wang, 2008, Journal of molecular biology.

Separation of the lipid bilayer from the membrane skeleton during discocyte-echinocyte transformation of human erythrocyte ghosts.

Shih-Chun Liu, L. Derick, S. Liu, 1989, European journal of cell biology.

Baseline characteristics of patients with atrial fibrillation: The AFFIRM Study

P. H. Beadle, A. Skadsen, S. Swiryn, 2002 .

A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR.

R. Khosravi‐Far, J. Lawler, B. Ren, 2009, Cancer Research.

Abstract B06: The angiotensin receptor blocker and partial PPARγ agonist telmisartan inhibits the growth of pancreatic ductal adenocarcinoma

R. Jain, Y. Boucher, M. V. Heiden, 2019 .

Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice

D. Fukumura, Meenal Datta, S. Roberge, 2023, Journal for ImmunoTherapy of Cancer.